As kidneys have one of the most diverse endothelial cell populations amongst organs and some of the hallmarks of kidney disease are endothelial dysfunction and reduced NO synthesis and bioavailability, we aimed to evaluate plasma kallikrein activity in individuals with type 1 diabetes and diabetic nephropathy. The gene discussed is KLK4; the disease is diabetic kidney disease.